The expert panel pressed Pfizer and the FDA on the shot’s safety, but ultimately were convinced by the potential for significant benefit in 5- to 11-year-olds.
The expert panel pressed Pfizer and the FDA on the shot’s safety, but ultimately were convinced by the potential for significant benefit in 5- to 11-year-olds.
Copyright © 2024 | WordPress Theme by MH Themes